Lilly has been solidly investing in research and development (R&D) throughout 2024. In April, the company announced the ...

Two companies — Eli Lilly and Novo Nordisk — dominate the weight-loss drug market and their stocks have surged in the recent ...

The U.S. Food and Drug Administration (FDA) is rethinking its decision to remove popular weight-loss and diabetes drugs from ...

The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder. This is the second study this fall to suggest ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

The logic suggested by the Lilly trial is the opposite, however. It proposes that being overweight is a primary cause of ...

Hims stock has rallied almost 22% this week on enthusiasm after the FDA said it will allow compounded versions of Lilly's ...

PRIVATE healthcare errand boy Wes Streeting has hit the streets running. His magic bullet for getting overweight people back to work is to ...

First patient dosed with ISP-001 shows reduced urinary GAG level, functional improvements surpassing enzyme replacement ...

India on Thursday weighed in on the ongoing diplomatic spat with Canada by holding the Trudeau administration responsible for 'precipitating' the current diplomatic fallout while acknowledging the ...

The race between Vice President Kamala Harris and former President Donald Trump remains a seeming dead heat less than three weeks before the election, according to a string of surveys that show ...